These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 2784985)

  • 1. Clinical effectiveness of desmopressin in a case of acquired von Willebrand's syndrome associated with benign monoclonal gammopathy.
    Castaman G; Rodeghiero F; Di Bona E; Ruggeri M
    Blut; 1989 Apr; 58(4):211-3. PubMed ID: 2784985
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyper-responsiveness to DDAVP for patients with type I von Willebrand's disease and normal intra-platelet von Willebrand factor.
    Rodeghiero F; Castaman G; Di Bona E; Ruggeri M; Lombardi R; Mannucci PM
    Eur J Haematol; 1988 Feb; 40(2):163-7. PubMed ID: 3126081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of von Willebrand's disease with desmopressin.
    Royer JE; Bates WS
    J Oral Maxillofac Surg; 1988 Apr; 46(4):313-4. PubMed ID: 2966240
    [No Abstract]   [Full Text] [Related]  

  • 4. Treatment of acquired von Willebrand syndrome in patients with monoclonal gammopathy of uncertain significance: comparison of three different therapeutic approaches.
    Federici AB; Stabile F; Castaman G; Canciani MT; Mannucci PM
    Blood; 1998 Oct; 92(8):2707-11. PubMed ID: 9763553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multimeric composition of factor VIII/von Willebrand factor following administration of DDAVP: implications for pathophysiology and therapy of von Willebrand's disease subtypes.
    Ruggeri ZM; Mannucci PM; Lombardi R; Federici AB; Zimmerman TS
    Blood; 1982 Jun; 59(6):1272-8. PubMed ID: 6805532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Intravenous administration of deamino-D-arginine-vasopressin (DDAVP) to patients with hemophilia A and von Willebrand's disease].
    Janczarski M; Ruszkowska I; Cetnarowicz H; Lopaciuk S
    Acta Haematol Pol; 1990; 21(1):16-21. PubMed ID: 2260405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intranasal desmopressin (DDAVP) by spray in mild hemophilia A and von Willebrand's disease type I.
    Lethagen S; Harris AS; Nilsson IM
    Blut; 1990 Mar; 60(3):187-91. PubMed ID: 2107887
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pregnancy and delivery in women with von Willebrand's disease and different von Willebrand factor mutations.
    Castaman G; Tosetto A; Rodeghiero F
    Haematologica; 2010 Jun; 95(6):963-9. PubMed ID: 19951969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myeloma and monoclonal gammopathy of uncertain significance associated with acquired von Willebrand's syndrome. Seven new cases with a literature review.
    Lamboley V; Zabraniecki L; Sie P; Pourrat J; Fournié B
    Joint Bone Spine; 2002 Jan; 69(1):62-7. PubMed ID: 11858359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unique multimeric pattern of von Willebrand factor in a patient with a benign monoclonal gammopathy.
    López-Fernández MF; López-Berges C; Martín R; Nieto J; del Rio F; López-Borrasca A; Batlle J
    Scand J Haematol; 1986 Mar; 36(3):302-8. PubMed ID: 3486452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acquired von Willebrand's syndrome: a single institution experience.
    Kumar S; Pruthi RK; Nichols WL
    Am J Hematol; 2003 Apr; 72(4):243-7. PubMed ID: 12666134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Response to desmopressin in type IID von Willebrand's disease.
    Thomas N; O'Callaghan U; Lowe GD; Olszynski V; Kernoff PB; Abildgaard CF; Tuddenham EG
    Clin Lab Haematol; 1989; 11(3):189-97. PubMed ID: 2591151
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness of high-dose intravenous immunoglobulin in a case of acquired von Willebrand syndrome with chronic melena not responsive to desmopressin and factor VIII concentrate.
    Castaman G; Tosetto A; Rodeghiero F
    Am J Hematol; 1992 Oct; 41(2):132-6. PubMed ID: 1415174
    [TBL] [Abstract][Full Text] [Related]  

  • 14. von Willebrand's disease: use of collagen binding assay provides potential improvement to laboratory monitoring of desmopressin (DDAVP) therapy.
    Favaloro EJ; Dean M; Grispo L; Exner T; Koutts J
    Am J Hematol; 1994 Mar; 45(3):205-11. PubMed ID: 8296790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies on the pathophysiology and treatment of von Willebrand's disease. V. Properties of factor VIII after DDAVP infusion in variant von Willebrand's disease.
    Takahashi H
    Thromb Res; 1981 Feb 15-Mar 1; 21(4-5):357-65. PubMed ID: 6791293
    [No Abstract]   [Full Text] [Related]  

  • 16. Association of von Willebrand's disease with plasma cell dyscrasia and gastrointestinal angiodysplasia.
    Rahmani R; Rozen P; Papo J; Iellin A; Seligsohn U
    Isr J Med Sci; 1990 Sep; 26(9):504-9. PubMed ID: 2121664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of deamino-8-D arginine vasopressin in a patient with moderate von Willebrand's disease.
    Abubaker AO; Bontempo FA; Braun TW
    J Oral Maxillofac Surg; 1987 Aug; 45(8):728-30. PubMed ID: 3497245
    [No Abstract]   [Full Text] [Related]  

  • 18. Diagnosis and management of von Willebrand's syndrome.
    Rick ME
    Med Clin North Am; 1994 May; 78(3):609-23. PubMed ID: 8170261
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platelet aggregation induced by 1-desamino-8-D-arginine vasopressin (DDAVP) in Type IIB von Willebrand's disease.
    Holmberg L; Nilsson IM; Borge L; Gunnarsson M; Sjörin E
    N Engl J Med; 1983 Oct; 309(14):816-21. PubMed ID: 6412139
    [TBL] [Abstract][Full Text] [Related]  

  • 20. No influence of blood group on the responsiveness to desmopressin in type I "platelet normal" von Willebrand's disease.
    Castaman G; Rodeghiero F
    Thromb Haemost; 1995 Mar; 73(3):551-2. PubMed ID: 7667843
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.